Takeda makes fourth offer to buy Shire
Shire welcomes Adderall generic ruling
designer491 / iStockphoto.com
Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Takeda, Shire, mergers and acquisitions, therapeutics, rare disease, M&A